BIOLOGY OF MENOPAUSE

Biology of menopause

The biology of menopause is a complex endocrine transition that marks the permanent cessation of menstruation and reproductive capability in women. According to the World Health Organization, menopause is clinically defined as the absence of menstrual periods for twelve consecutive months, usually occurring between 45 and 55 years of age. This biological event is not a sudden process but rather the culmination of gradual ovarian aging and hormonal decline that begins several years before the final menstrual period.

The primary biological basis of menopause is the depletion of ovarian follicular reserve. Women are born with a finite number of oocytes stored within the ovarian cortex. With advancing age, these follicles undergo atresia, and the number of functioning primordial follicles declines progressively. When the follicular pool falls below a critical threshold, the ovary loses its ability to respond adequately to gonadotropins, leading to reduced estrogen production. The decline in ovarian function is mainly attributed to aging granulosa cells and impaired steroidogenesis.

Hormonal regulation plays a central role in the biology of menopause. During the reproductive years, the hypothalamic-pituitary-ovarian axis maintains cyclical hormonal secretion. As ovarian follicles diminish, secretion of estradiol and inhibin decreases. Reduced inhibin levels remove negative feedback inhibition on follicle-stimulating hormone (FSH) secretion, resulting in elevated circulating FSH levels. Luteinizing hormone (LH) levels also rise but to a lesser extent. The hallmark biochemical feature of menopause is therefore high gonadotropins combined with low estrogen concentrations.

The perimenopausal transition represents the phase of hormonal instability preceding menopause. During this period, menstrual cycles become irregular due to inconsistent ovulation. Some cycles are anovulatory because follicles fail to mature properly. Estrogen levels may fluctuate widely, sometimes causing episodes of endometrial proliferation followed by breakthrough bleeding. Progesterone deficiency becomes common because ovulation is sporadic, contributing to menstrual irregularity and symptomatic complaints.

Estrogen deficiency affects multiple organ systems because estrogen receptors are distributed widely throughout the body. The reproductive tract undergoes structural and functional changes. The vaginal epithelium becomes thin, less elastic, and poorly lubricated due to reduced glycogen content and decreased lactobacilli population. This alteration predisposes women to vaginal dryness, dyspareunia, and recurrent urinary tract infections.

The cardiovascular system is also influenced by declining estrogen levels. Estrogen has protective effects on lipid metabolism by increasing high-density lipoprotein levels and reducing low-density lipoprotein concentrations. After menopause, many women experience unfavorable lipid profile changes, increasing the risk of atherosclerosis and coronary artery disease. Epidemiological observations have shown that cardiovascular risk in women rises significantly after menopause, narrowing the gender gap in heart disease incidence.

Bone metabolism is another critical biological aspect of menopause. Estrogen plays an essential role in maintaining bone density by inhibiting osteoclast-mediated bone resorption. When estrogen levels fall, bone resorption accelerates, leading to decreased bone mineral density and increased susceptibility to fractures. Postmenopausal osteoporosis is a major public health concern and is extensively studied by the North American Menopause Society.

Thermoregulatory instability is responsible for vasomotor symptoms such as hot flashes and night sweats. The exact mechanism is not fully understood, but hypothalamic thermoregulatory centers appear to become more sensitive due to estrogen withdrawal. Small changes in core body temperature may trigger inappropriate peripheral vasodilation and sweating episodes. Neurotransmitters such as serotonin and norepinephrine are believed to be involved in symptom generation.

Cognitive and psychological effects are also associated with menopause. Some women report mood disturbances, anxiety, irritability, and memory difficulties during the menopausal transition. Although the relationship between estrogen deficiency and cognitive decline is still under research, estrogen is known to influence neuronal plasticity and cerebral blood flow. Lifestyle factors, genetic susceptibility, and psychosocial environment also contribute significantly to psychological outcomes.

Metabolic changes occur after menopause due to altered fat distribution and reduced basal metabolic rate. There is a tendency toward central obesity, insulin resistance, and metabolic syndrome. Adipose tissue becomes an important site of peripheral estrogen synthesis through aromatization of androgens, partially compensating for ovarian estrogen loss.

The endocrine changes of menopause are also characterized by increased gonadotropin-releasing hormone pulsatility from the hypothalamus. This alteration reflects reduced negative feedback inhibition by ovarian hormones. Additionally, androgen levels decline gradually but at a slower rate compared to estrogen. Some women may experience relative androgen excess, contributing to symptoms such as hirsutism or acne.

Genetic and environmental factors influence the timing of menopause. Smoking, chronic illness, chemotherapy exposure, and autoimmune diseases may accelerate ovarian aging. Conversely, factors such as better nutrition and improved healthcare may delay menopausal onset.

Understanding the biology of menopause is important for developing therapeutic strategies. Hormone replacement therapy, lifestyle modification, calcium and vitamin D supplementation, and regular exercise are commonly recommended approaches for managing menopausal health risks. Individualized treatment based on symptom severity, medical history, and risk assessment is essential.

In conclusion, menopause represents a natural biological transition resulting from ovarian aging and endocrine alterations. The decline in estrogen production affects reproductive, skeletal, cardiovascular, metabolic, and neuropsychological functions. Ongoing research continues to improve understanding of menopausal biology and optimize health outcomes for aging women.